Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-065962
Filing Date
2025-07-21
Accepted
2025-07-21 11:23:18
Documents
1
Period of Report
2025-07-21

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0249696-6k_xtlbiopharma.htm 6-K 11234
  Complete submission text file 0001213900-25-065962.txt   12285
Mailing Address 26 BEN-GURION ST. RAMAT GAN L3 5112001
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-36000 | Film No.: 251136250
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)